GenomeNext, LLC, is a leader in genomic data management and integrated analysis, offering a proprietary genomic analysis platform that delivers clinically validated precision enabling more effective and accurate variant calling leading to the discovery of a more comprehensive and reproducible list of candidate biomarkers for further evaluation; a primary factor in selecting GenomeNext for sequence analysis and interpretation.
We focus on automated informatics and data management solutions designed to simplify, expedite and enhance analysis workflows to significantly advance medical research and expand understanding of the basis, treatment and prevention of complex diseases by aggregate population scale analysis. Our solutions provide the market with genomic data and analysis at an unprecedented combination of quality, cost, and scale without requiring the investment in high-performance computing resources and specialized personnel.
Our proprietary platforms address a broad range of highly interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. Our customers include leading genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies.